Xiaoqi Lin

Dr. Xiaoqi Lin


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Korean Journal of Radiology
Verified
Journal Article
Open access
PDF file
XLXiaoqi Lin
Xiaoqi Lin
ZGZhenyu Gong
Zhenyu Gong
ZXZuke Xiao
Zuke Xiao
JXJingliang Xiong
Jingliang Xiong
BFBing Fan
Bing Fan
JLJiaqi Liu
Jiaqi Liu
Lin X, et al. Korean J Radiol. 2020 Jan;21:e12. https://doi.org/10.3348/kjr.2020.0078

15 July 2008 in Journal of Molecular Endocrinology
Verified
Journal Article
Open access
PDF file
XLXiaoqi Lin
Xiaoqi Lin
SFSydney D Finkelstein
Sydney D Finkelstein
BZBing Zhu
Bing Zhu
JSJan F Silverman
Jan F Silverman
Papillary thyroid carcinoma (PTC) frequently presents as a multifocal process. To study the importance of separating independent primary (IP) from intrathyroid metastatic (ITM) PTC, we examined 19 molecular markers on 42 separate tumors from 18 multifocal PTC cases. In 12 of 18 (66.7%) cases, including 6 of 12 (50%) papillary microcarcinoma cases, the same or similar profile of loss of heterozygosities (LOH) and v-raf murine sarcoma viral oncogene homolog B1 (BRAF) mutation was demonstrated, indicating that they were from the same primary and represented ITM. Different profiles of LOHs and BRAF mutation were detected in separate tumors of 6 of 18 cases, indicating that they represented IP. Patients with ITM, including papillary microcarcinoma, had significantly increased lymph node metastasis. The frequencies of LOHs of 17q21, 17p13, 10q23, and 22q13 were higher in tumors with lymph node metastasis, suggesting that these LOHs may be important in increased lymph node metastasis. LOH of 9p21 was found at the highest frequency in PTC (53.8%), followed by 1p36 (46.2%), 10q23 (34.6%), and 22q13 (34.6%). Papillary microcarcinoma had acquired similar genomic mutations as conventional PTC, but higher frequencies of mutations of BRAF, 1p36, 18q, and 22q13 were found in the larger PTC, suggesting that they might play a role in the aggressiveness of PTC. Different profiles of mutations were observed in conventional, follicular variants, and diffuse sclerosing variant of PTC, which might influence the different morphological appearances and clinical courses. In conclusion, molecular analysis can separate multifocal IP PTC from ITM PTC, and may be more important than tumor size in predicting lymph node metastasis, aggressiveness, and prognosis of PTC.

1 October 2016 in Human Pathology
Verified
Journal Article
Closed access
XLXiaoqi Lin
Xiaoqi Lin
SDSimone Davion
Simone Davion
EBElizabeth C. Bertsch
Elizabeth C. Bertsch
IOImran Omar
Imran Omar
RNRitu Nayar
Ritu Nayar
WLWilliam B. Laskin
William B. Laskin

22 January 2010 in Diagnostic Pathology
Verified
Journal Article
Open access
PDF file
XLXiaoqi Lin
Xiaoqi Lin
BZBing Zhu
Bing Zhu
YLYulin Liu
Yulin Liu
JSJan F Silverman
Jan F Silverman
Follicular thyroid carcinoma (FTC) tends to metastasize to remote organs rather than local lymph nodes. Separation of FTC from follicular thyroid adenoma (FTA) relies on detection of vascular and/or capsular invasion. We investigated which vascular markers, CD31, CD34 and D2-40 (lymphatic vessel marker), can best evaluate vascular invasion and why FTC tends to metastasize via blood stream to remote organs. Thirty two FTCs and 34 FTAs were retrieved for evaluation. The average age of patients with FTA was 8 years younger than FTC (p = 0.02). The female to male ratio for follicular neoplasm was 25:8. The average size of FTC was larger than FTA (p = 0.003). Fourteen of 32 (44%) FTCs showed venous invasion and none showed lymphatic invasion, with positive CD31 and CD34 staining and negative D2-40 staining of the involved vessels. The average number of involved vessels was 0.88 ± 1.29 with a range from 0 to 5, and the average diameter of involved vessels was 0.068 ± 0.027 mm. None of the 34 FTAs showed vascular invasion. CD31 staining demonstrated more specific staining of vascular endothelial cells than CD34, with less background staining. We recommended using CD31 rather than CD34 and/or D2-40 in confirming/excluding vascular invasion in difficult cases. All identified FTCs with vascular invasions showed involvement of venous channels, rather than lymphatic spaces, suggesting that FTCs prefer to metastasize via veins to distant organs, instead of lymphatic vessels to local lymph nodes, which correlates with previous clinical observations.

27 November 2014 in Diagnostic Cytopathology
Verified
Journal Article
Closed access
PDF file
MJMatthew Jurczyk
Matthew Jurczyk
JPJoseph F. Peevey
Joseph F. Peevey
MHMark A. Vande Haar
Mark A. Vande Haar
XLXiaoqi Lin
Xiaoqi Lin

7 January 2011 in Cytopathology
Verified
Journal Article
Closed access
PDF file
BZB. Zhu
B. Zhu
WLW. Laskin
W. Laskin
YCY. Chen
Y. Chen
CFC. A. French
C. A. French
MCM. J. Cameron
M. J. Cameron
XLXiaoqi Lin
Xiaoqi Lin